Cargando…
Gene panel testing for breast cancer should not be used to confirm syndromic gene associations
Autores principales: | Evans, D. Gareth, Howell, Sacha J., Frayling, Ian M., Peltonen, Juha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255919/ https://www.ncbi.nlm.nih.gov/pubmed/30510771 http://dx.doi.org/10.1038/s41525-018-0071-6 |
Ejemplares similares
-
Metaplastic breast cancer and BRCA1: first strong evidence of a link
por: Evans, D. Gareth R, et al.
Publicado: (2023) -
Extended gene panel testing in lobular breast cancer
por: van Veen, Elke M., et al.
Publicado: (2021) -
Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability
por: Evans, D. Gareth, et al.
Publicado: (2021) -
Comment on “Validation of a Blood-Based Laboratory Test to Aid in the Confirmation of a Diagnosis of Schizophrenia”
por: Kingsmore, Stephen F
Publicado: (2014) -
Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy?
por: Evans, D. Gareth, et al.
Publicado: (2019)